Join
Live feed
·
INSIDERFilingvia Quantisnow
Monte Rosa Therapeutics Inc. logo

Principal Accounting Officer Dunn Edmund sold $2,496 worth of shares (139 units at $17.96), decreasing direct ownership by 0.61% to 22,554 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GLUE (Monte Rosa Therapeutics Inc.) and more on Quantisnow.